The only free news source for serious moves across finance

M&A

Latest m&a news and updates

MA

Prosperity Bancshares to Acquire Southwest Bancshares in Strategic Merger Valued at $72.83 per Share

Prosperity Bancshares, Inc. has proposed a merger with Southwest Bancshares, Inc., in a move that will consolidate their market presence in Texas banking. The deal will see SWBI shareholders receive Prosperity shares valued at $72.83 each, pending shareholder approval on January 22, 2026.

In a significant corporate action, Prosperity Bancshares, Inc. (NYSE: PB) has entered into a merger agreement with Southwest Bancshares, Inc. (SWBI), aimed at enhancing their competitive edge in the Texas banking sector. This merger, announced on September 30, 2025, is set to create a larger entity with a more extensive market footprint. The merger will involve the consolidation of SWBI into Prosperity, with Prosperity emerging as the surviving corporation. Following this initial merger, Texas Partners...
USFM • Dec 16, 2:24 PM
MA

Volato Group and M2i Global Inc. Enter Strategic Merger Agreement to Enhance Business Synergies

Volato Group, Inc. has announced a definitive merger agreement with M2i Global Inc., aimed at creating a more robust company poised to leverage shared resources and capabilities. The transaction, valued at approximately $200 million, is expected to close in the second half of 2025, pending regulatory approvals.

In a significant corporate move, Volato Group, Inc. has entered into a merger agreement with M2i Global Inc. This strategic transaction, valued at around $200 million, marks a notable consolidation within the aviation sector, aiming to enhance operational efficiencies and market competitiveness for both companies. **Who is Involved**: The primary entities in this merger are Volato Group, Inc. and M2i Global Inc. Both companies are recognized players within the aviation industry, with Volato focusing on...
USFM • Dec 16, 3:24 AM
MA

Volato Group, Inc. to Merge with M2i Global, Inc. in Strategic Deal

Volato Group, Inc. has announced a merger agreement with M2i Global, Inc., aiming to enhance operational capabilities and market reach. The transaction, which is expected to close by late 2025, reflects a strategic move to capitalize on synergies and expand service offerings in the aerospace sector.

In a significant move within the aerospace sector, Volato Group, Inc. (Ticker: VLTO) has entered into a merger agreement with M2i Global, Inc. The deal is poised to combine the strengths of both companies, enhancing their operational capabilities and market presence. While specific financial terms such as deal value and exchange ratios are yet to be disclosed in detail, the merger reflects a broader strategy to leverage synergies and optimize resources in a competitive landscape.
USFM • Dec 15, 5:25 PM
MA

Volato Group Enters Merger Agreement with M2i Global Inc., Aiming for Strategic Expansion

Volato Group, Inc. has announced a merger agreement with M2i Global Inc., a move intended to bolster operational synergies and market presence. Expected to close by the end of 2025, this merger highlights a strategic alignment aimed at enhancing shareholder value and expanding service offerings.

In a significant corporate move, Volato Group, Inc. has entered into a merger agreement with M2i Global Inc. The deal is set to reshape the operational landscape for both companies, creating a more comprehensive entity poised for growth in their respective markets. ### Overview of the Merger The merger between Volato Group and M2i Global Inc. aims to leverage the combined strengths of both firms, enhancing their market competitiveness and operational efficiencies. This agreement comes...
USFM • Dec 15, 2:25 PM
MA

BioCryst Pharmaceuticals to Acquire Astria Therapeutics in Strategic Merger Deal Valued at $8.55 per Share

BioCryst Pharmaceuticals, Inc. has announced a definitive merger agreement with Astria Therapeutics, Inc., under which Astria will become a wholly owned subsidiary of BioCryst. The transaction values Astria shareholders at approximately $12.70 per share, comprising a mix of BioCryst stock and cash.

In a significant move within the biotech industry, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has entered into a merger agreement with Astria Therapeutics, Inc. (NASDAQ: ATXS) that will see Astria merge with a wholly owned subsidiary of BioCryst, known as Axel Merger Sub, Inc. This strategic transaction, announced on October 14, 2025, aims to enhance BioCryst's portfolio and expand its capabilities in developing innovative therapies. Under the terms of the merger agreement, each outstanding share of...
USFM • Dec 15, 1:41 PM
MA

HBT Financial, Inc. to Acquire CNB Bank Shares, Inc. in Strategic Merger Valued at $165.4 Million

HBT Financial, Inc. has entered into a merger agreement to acquire CNB Bank Shares, Inc. in a deal valued at approximately $165.4 million. This strategic transaction aims to enhance HBT's market presence and create value for shareholders through expanded operations.

HBT Financial, Inc. (HBT) is set to acquire CNB Bank Shares, Inc. (CNB) in a significant merger agreement that was finalized on October 20, 2025. The deal, which is valued at approximately $165.4 million, involves a phased approach where CNB will first merge with a newly formed subsidiary of HBT, HB-CNB Merger, Inc. (MergerCo), before CNB merges into HBT itself, making CNB a wholly-owned subsidiary of HBT. Under the terms of the merger agreement, CNB...
USFM • Dec 14, 11:16 AM
MA

HBT Financial to Acquire CNB Bank Shares in Strategic Merger Valued at $165.4 Million

HBT Financial, Inc. has announced its plan to merge with CNB Bank Shares, Inc., creating a significant consolidation in the banking sector. The transaction, valued at approximately $165.4 million, will see CNB become a wholly-owned subsidiary of HBT, with shareholders receiving a mix of cash and stock as merger consideration.

In a pivotal move for the banking sector, HBT Financial, Inc. (HBT) has entered into a definitive merger agreement with CNB Bank Shares, Inc. (CNB), which is set to reshape the landscape for both companies. This merger, officially announced on October 20, 2025, will result in CNB merging into HBT, with CNB as the surviving entity initially, followed by an intermediate merger where CNB will cease to exist as a separate corporate entity. The merger...
USFM • Dec 12, 10:20 PM
MA

Fulton Financial Corporation to Acquire Blue Foundry Bancorp in $243 Million All-Stock Merger

Fulton Financial Corporation has entered into a definitive agreement to acquire Blue Foundry Bancorp in an all-stock merger valued at approximately $243 million. The deal will see Blue Foundry merge into Fulton, with a proposed exchange ratio of 0.650 shares of Fulton common stock for each share of Blue Foundry common stock.

Fulton Financial Corporation, a Pennsylvania-based financial services company, is set to acquire Blue Foundry Bancorp, a New Jersey-chartered bank holding company, in a significant all-stock merger valued at approximately $243 million. This merger, formalized in an Agreement and Plan of Merger dated November 24, 2025, will allow Fulton to expand its footprint while enhancing its service offerings. Under the terms of the merger agreement, each share of Blue Foundry common stock will be exchanged for...
USFM • Dec 12, 10:20 PM
MA

Crescent Biopharma, Inc. Announces Merger Agreement to Expand Market Reach and Enhance Product Pipeline

Crescent Biopharma, Inc. has entered into a definitive merger agreement aimed at bolstering its market presence and accelerating growth. The transaction is set to strategically align Crescent with key therapeutic development initiatives while enhancing shareholder value.

Crescent Biopharma, Inc. has announced a definitive merger agreement that will position the company for accelerated growth and enhanced operational efficiencies. This strategic move aims to combine resources and expertise, enabling Crescent to expand its product pipeline and market reach effectively. **Who is Involved**: The primary entity in this merger is Crescent Biopharma, Inc. (CBIO), which is merging with a target company to be determined, as per the filings. This agreement is set to streamline...
USFM • Dec 12, 3:22 PM
MA

Waters Corporation to Acquire Becton, Dickinson's Biosciences Division in Strategic Merger

Waters Corporation has entered into a definitive agreement to merge with Becton, Dickinson and Company's Biosciences & Diagnostic Solutions business. This transaction aims to enhance Waters' position as a leader in life science tools and diagnostics, with expected synergies totaling $345 million.

In a significant strategic move, Waters Corporation has announced its plans to merge with Becton, Dickinson and Company’s Biosciences & Diagnostic Solutions business. This merger, formalized in a definitive agreement dated July 14, 2025, is poised to bolster Waters' capabilities in high-growth markets within the life sciences sector. The deal is anticipated to create substantial value for both companies by leveraging complementary technologies and customer channels. ### Key Players Involved The primary entities in this...
USFM • Dec 12, 12:42 PM
MA

Kimberly-Clark to Acquire Kenvue in Strategic Merger Valued at Approximately $21.01 Per Share

Kimberly-Clark Corporation (K-C) has announced a definitive merger agreement to acquire Kenvue Inc. in a transaction that will see Kenvue become a wholly owned subsidiary of K-C. Shareholders of Kenvue are expected to receive a combination of Kimberly-Clark stock and cash, valuing the deal at approximately $21.01 per share based on recent stock prices.

In a significant move within the consumer goods sector, Kimberly-Clark Corporation, known for its trusted brands, has entered into a merger agreement with Kenvue Inc., a company focused on consumer health products. This strategic transaction will involve a two-step merger process, where Kenvue will first merge with a wholly-owned subsidiary of K-C, making Kenvue a direct wholly-owned subsidiary of Kimberly-Clark, followed by a subsequent merger involving Kenvue's newly formed entity. The deal structure provides Kenvue...
USFM • Dec 12, 12:42 PM
MA

Farmers National Banc Corp to Merge with Middlefield Banc Corp in Strategic Deal Valued at Approximately $36.22 per Share

Farmers National Banc Corp has announced a merger agreement with Middlefield Banc Corp, where Middlefield will be absorbed into Farmers at a fixed exchange ratio of 2.6 Farmers shares for each Middlefield share. This merger, valued at approximately $36.22 per share based on recent market prices, is set to enhance Farmers' market position and shareholder value.

In a significant move within the banking sector, Farmers National Banc Corp (FMNB) is poised to merge with Middlefield Banc Corp (MBCN) following the agreement reached by both companies' boards of directors. The merger, formalized under an Agreement and Plan of Merger dated October 22, 2025, will see Middlefield merging into Farmers, with Farmers continuing as the surviving entity. Immediately after this merger, Middlefield’s wholly-owned bank subsidiary, The Middlefield Banking Company, will merge with Farmers’...
USFM • Dec 12, 1:29 AM
MA

Farmers National Banc Corp to Acquire Middlefield Banc Corp in Strategic Merger

Farmers National Banc Corp has announced its intention to merge with Middlefield Banc Corp, creating a combined entity poised for growth in the Ohio banking sector. Under the terms of the merger, Middlefield shareholders will receive 2.6 shares of Farmers common stock for each share they hold, valued at approximately $36.22 based on recent market prices.

In a significant move within the Ohio banking landscape, Farmers National Banc Corp (FMNB) has entered into a definitive merger agreement to acquire Middlefield Banc Corp (MBCN). This merger, confirmed by both boards of directors, is set to consolidate the two banks, with Farmers continuing as the surviving entity. The merger is expected to provide strategic benefits, enhancing operational efficiencies and expanding market reach in the region. At the heart of this transaction is the...
USFM • Dec 11, 10:20 PM
MA

Blackboxstocks Inc. to Acquire REalloys Inc. in Strategic Merger Agreement

Blackboxstocks Inc. has announced its plans to acquire REalloys Inc. through a merger agreement, which will significantly reshape the ownership structure and market positioning of both companies. The deal, valued at approximately $38 million, involves a stock exchange ratio and is expected to close in early 2026 pending shareholder approvals.

In a significant move within the financial landscape, Blackboxstocks Inc. (NASDAQ: BLBX) has entered into a merger agreement to acquire REalloys Inc., a Nevada corporation specializing in advanced materials. The agreement, initiated on March 10, 2025, marks a critical step in Blackboxstocks' strategic expansion plans and aims to leverage REalloys' innovative capabilities in the market. The merger involves RABLBX Merger Sub, Inc., a wholly owned subsidiary of Blackboxstocks, which will merge with REalloys, allowing REalloys...
USFM • Dec 11, 7:20 PM
MA

Blackboxstocks to Merge with REalloys in Strategic Move to Enhance Market Position

In a significant corporate action, Blackboxstocks Inc. has announced its merger with REalloys Inc., a move poised to create a stronger combined entity in the financial technology space. The merger, valued at an undisclosed amount, is set to enhance shareholder value and expand product offerings.

In a strategic development within the financial technology sector, Blackboxstocks Inc. (NASDAQ: BLBX) has entered into a merger agreement with REalloys Inc., effective March 10, 2025. This transaction involves Blackboxstocks' wholly owned subsidiary, RABLBX Merger Sub, Inc., merging with REalloys, with REalloys continuing as the surviving corporation. Following the merger, the combined entity is expected to be renamed REalloys Inc., enhancing visibility in the market. The financial implications of this merger are notable. REalloys stockholders...
USFM • Dec 11, 5:26 PM
MA

FirstSun Capital Bancorp to Acquire First Foundation Inc. in Strategic Merger Valued at $6.46 per Share

FirstSun Capital Bancorp has entered into a definitive agreement to acquire First Foundation Inc. in a merger that will transform the combined entity into a premier bank in the Southwest with approximately $17 billion in assets. The transaction will see First Foundation shareholders receive 0.16083 shares of FirstSun common stock for each share they own, valuing the deal at $6.46 per share based on recent stock prices.

In a significant move within the financial sector, FirstSun Capital Bancorp (NASDAQ: FSUN) has announced its intention to acquire First Foundation Inc. (NYSE: FFWM) in a strategic merger agreement that aims to create a larger and more diversified banking institution. The merger agreement, reached on October 27, 2025, will result in First Foundation merging with FirstSun, with FirstSun continuing as the surviving corporation. Following this initial merger, First Foundation's wholly-owned subsidiary, First Foundation Bank, will...
USFM • Dec 11, 3:24 PM
MA

FirstSun Capital Bancorp to Merge with First Foundation Inc. in Strategic $6.46 Per Share Deal

FirstSun Capital Bancorp has entered into a merger agreement with First Foundation Inc., establishing a combined entity with approximately $17 billion in assets. The deal, valued at $6.46 per share based on FirstSun's closing stock price, aims to enhance capital position and diversify business models.

In a significant corporate development, FirstSun Capital Bancorp (NASDAQ: FSUN) has agreed to merge with First Foundation Inc. (NYSE: FFWM), a transaction that is poised to create a premier banking institution in the Southwest with approximately $17 billion in assets. The merger agreement, finalized on October 27, 2025, outlines a strategic plan for both companies, with FirstSun continuing as the surviving corporation post-merger. Under the terms of the merger, shareholders of First Foundation will receive...
USFM • Dec 11, 2:23 PM
MA

Coeptis Therapeutics Announces Merger Agreement to Enhance Biopharmaceutical Capabilities

Coeptis Therapeutics Holdings, Inc. has entered into a definitive merger agreement that will significantly bolster its position in the biopharmaceutical sector. This strategic move aims to accelerate growth and enhance product development capabilities, positioning Coeptis for future success.

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) has announced a definitive merger agreement as part of its strategic plan to enhance its capabilities within the biopharmaceutical industry. The merger is expected to create a more robust organization, positioning Coeptis to better serve its shareholders and enhance its product offerings. The merger involves the acquisition of Coeptis Therapeutics by an undisclosed partner, which is designed to leverage synergies between the two companies. While the specific financial terms...
USFM • Dec 11, 9:25 AM
MA

Coeptis Therapeutics to Acquire SNAP Biosciences in Strategic Merger Deal

Coeptis Therapeutics Holdings, Inc. has announced its intention to acquire SNAP Biosciences, Inc. in a strategic merger aimed at enhancing its portfolio in the biotechnology sector. The transaction is expected to close in the second quarter of 2025, pending regulatory approvals and shareholder consent.

In a significant move within the biotechnology industry, Coeptis Therapeutics Holdings, Inc. (OTC: COEP) has unveiled plans to acquire SNAP Biosciences, Inc. This merger aims to combine resources and expertise, positioning Coeptis for accelerated growth in the competitive biotech landscape. **Transaction Details**: The deal outlines a merger agreement where Coeptis will acquire SNAP Biosciences in an all-stock transaction. While specific financial terms such as deal value and exchange ratios have not been disclosed in the...
USFM • Dec 11, 3:25 AM
MA

Rayonier and PotlatchDeltic to Merge in $1.4 Billion Transaction: A Strategic Merger of Equals

Rayonier Inc. has announced a merger agreement with PotlatchDeltic Corporation, forming a new entity through a merger of equals valued at approximately $1.4 billion. This strategic transaction will see PotlatchDeltic merge into Rayonier's wholly owned subsidiary, Redwood Merger Sub, creating a more robust forestry and land management company.

In a significant corporate development, Rayonier Inc. (NYSE: RYN) has entered into a definitive merger agreement with PotlatchDeltic Corporation (NASDAQ: PCH) to create a combined entity through a merger of equals. The agreement, finalized on October 13, 2025, outlines that PotlatchDeltic will merge with Redwood Merger Sub, LLC, a wholly owned subsidiary of Rayonier, with the subsidiary surviving the merger. The financial terms of the deal specify that each share of PotlatchDeltic common stock will...
USFM • Dec 10, 11:18 PM